Feb 232016
 

By Talent4Boards Team

Talent4Boards – Great Talent builds Great Boards

– USA, MA – Pronutria Biosciences Inc., a biotechnology company pioneering first-in-class medicines for serious conditions linked to amino acid imbalances, announced today that it has completed a $42.5 million investment by Nestlé Health Science.

The proceeds from this financing will help to fund the ongoing rapid transformation of the company from a unique and revolutionary platform to late stage clinical candidates in several disease indications.… => more

Pronutria Biosciences announces Greg Behar to its Board along with $42.5m Equity Investment from Nestle Health Science

From:: Pronutria Biosciences announces Greg Behar to its Board along with $42.5m Equity Investment from Nestle Health Science

 Posted by at 2:24 pm

Sorry, the comment form is closed at this time.

%d bloggers like this: